[ad_1]
New Delhi: The government is planning to launch a new scheme to encourage youth working in the medtech or healthcare sector. Medical Technology Industry To Manufacture of components For digital X-Ray, CT Scan and MRI machines in the country.
Currently, most of such components are imported, which increases the cost of equipment and, consequently, the cost of medical imaging.
Speaking at an event, Pharma Secretary Arunish Chawla said – MedTech Stackathon – held in New Delhi on Wednesday, told TOI that the government is making fresh efforts to promote Medical Equipment Manufacturing New incentives have been introduced in the country.
“One of the incentives being planned is to provide 20 per cent capital subsidy on marginal investment to select companies,” he said. Investment in manufacturing “A wide range of components required to build digital X-ray, CT scan, MRI and other such devices are available,” Chawla said.
In the Union Budget 2024-25, the government announced reduction in customs duty on X-ray tubes and flat panel detectors, key components of digital X-ray machines. Government sources said that Phased manufacturing program (PMP) was notified by Department of Pharmaceuticals On 22 January 2021 Promoting domestic manufacturing Changes in tariff were proposed for procurement of Medical X-Ray machines and specified sub-assemblies/parts/sub-parts at an increasing rate in a phased manner.
However, a source said the industry told the Department of Pharmaceuticals that manufacturing capability for X-ray tubes and flat panel detectors is yet to be developed in the country and requested amendment in the PMP schedule relating to these items.
“After careful examination in this regard, it was found that it may take at least two years to set up adequate domestic capacity for X-ray tubes and flat panel detectors to meet the domestic requirement. Following this, the Department of Pharmaceuticals requested the Revenue Department for revised rates, which has now been done,” an official said.
Meditech Stackathon 2024 is an exercise being conducted by the Department of Pharmaceuticals in collaboration with the industry aimed at identifying critical issues impeding growth. Medical Device IndustrySuch as dependence on imports, regulatory hurdles and technological gaps.
Dr Harsh Mahajan, Chairman and Founder of Mahajan Imaging, who is also the Chairman of FICCI’s Healthcare Committee, said, “At present, digital X-ray machines being imported from the US and China cost anywhere between Rs 18 lakh to Rs 1 crore. If domestic manufacturing succeeds, the same machines can be made at a much lower cost, which will eventually lead to a reduction in imaging using this equipment. Also, it may be more viable to ensure wider availability of X-ray machines, including at primary healthcare centres spread across the country.”
India is known as the pharmacy of the world because of its generic medicines and low-cost vaccines. It has the highest number of United States Food and Drug Administration (USFDA) compliant pharma plants outside the US. However, in the medical device sector, the country is highly dependent on imports and about 70 per cent of the products are sourced from other countries.
[ad_2]
Source link